Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Neuronetics, Inc.

Get SEC filing alerts via email and in your feed for Neuronetics, Inc.

STIM

Neuronetics, Inc.

About Neuronetics, Inc.

Neuronetics, Inc. develops non-invasive neurohealth treatments, primarily using transcranial magnetic stimulation (TMS) for major depressive disorder (MDD) and other mental health conditions. Its flagship product, the NeuroStar Advanced Therapy System, delivers precise magnetic pulses to stimulate mood-related brain areas. The company operates in the U.S. and internationally, serving psychiatrists and mental health providers with clinical data-backed solutions, practice support, and expanding indications in the neurotherapy market.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Neuronetics, Inc.

1
1
Neuronetics, Inc. Neuronetics Reports $34.5 Million Revenue with 8% Growth, Net Loss Improves

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Neuronetics, Inc. Neuronetics Reports 99% Revenue Growth to $149.2 Million in Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Neuronetics, Inc. Neuronetics Reports 101% Revenue Growth to $37.3 Million in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Neuronetics, Inc. Neuronetics Reports 132% Revenue Growth to $38.1 Million in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Neuronetics, Inc. Neuronetics Reports 84% Revenue Growth to $31.975 Million, Net Loss Increases

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Neuronetics, Inc. Neuronetics Reports 5% Revenue Increase to $74.9 Million, Faces $43.7 Million Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Neuronetics, Inc. Neuronetics Reports Mixed Q3 2024 Results with Revenue Growth and Increased Loss

Via official filing (AI summary) | over 1 year ago | 0 comments